RT @c_garciavidal: More news on hydroxychloroquine treatment for covid19. But again the same mistake: 7 days median time from starting symp…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
RT @GuillermoRuizA5: One more nail in the coffin of #hydroxycloroquine in #Covid_19 https://t.co/ihXf3MJVq0
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19: https://t.co/n2uURye4hs
@angotti_neto E por falar em evidências... https://t.co/62SKt6KKPG
RT @GermHunterMD: Another RCT of HCQ in hospitalized patients with COVID19, this time limited to mild-to-moderate severity (<4 L of O2), an…
One more nail in the coffin of #hydroxycloroquine in #Covid_19 https://t.co/ihXf3MJVq0
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
RT @Barbusceptique: HCQ, fin de partie numéro 36.
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM @AMCI_Colombia @crdc2001 @Dr_G_Ortiz @ucisantaclara https://t.co/GHGatQUuoe
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/4F4835OApo
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
No effect of HCQ +/- azithromycin in mild-moderate Covid19:
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @Barbusceptique: HCQ, fin de partie numéro 36. https://t.co/2p9MDY7FGF
RT @c_garciavidal: More news on hydroxychloroquine treatment for covid19. But again the same mistake: 7 days median time from starting symp…
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/tcS1e0FkJB by @NEJM #Covid_19 #MedEd https://t.co/iUs0xotqft
Segue o 🧶
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
Great to see this level of collaboration in Brazil in such hard times. I hope Brazilians take the results of this study seriously. Congratulations to the authors! #MedTwitter
Gostaria de saber qual é o posicioanmento da @AMB_oficial @SBInfectologia @minsaude sobre esse trabalho feito nos maiores hospitais do país
O desenho do estudo é bom. Randomizado e prospectivo. Mas nenhum estudo é perfeito. Casos leves ou moderados. Sem melhora! https://t.co/Wkt8IlZp14
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @dadourado: Acaba de ser publicado estudo de pesquisadores brasileiros no @NEJM. Resultado: FALTA DE EFICÁCIA DA HIDROXICLOROQUINA PARA…
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
Among patients hospitalized with mild-to-moderate Covid-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care. https://t.co/uvrJsgayGT
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @amelie_for_you: RCT au Brésil et EI cardiaques 😱😔👇 #COVID19 #Raoult #RaoultPasContent
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
Otro estudio mas...
More news on hydroxychloroquine treatment for covid19. But again the same mistake: 7 days median time from starting symptoms to randomization. 😱😱 No way!! Otherwise, hydroxy should not be used anymore. @ESCMID @SEIMC_ @ASMicrobiology https://t.co/Ooh
One more for the road
“Among patients hospitalized with mild-to-moderate Covid-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care.” https://t.co/ghXqGCGL9t
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @DrChoueiri: Just NOW in @NEJM —another RCT of #HCQ this time from Brazil showing no benefit in #COVID19 (with minimal O2 req) https://t…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @drmiguelmarcos: Otro estudio randomizado que NO muestra eficacia de la hidroxicloroquina (ni con azitromicina) en #COVID19 Probablement…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @Rfonsi1: Hats off to the Brazilian team. Unfortuntaley, no evidence of benefit for HCQ. "The first patient underwent randomization on…
RT @mtmdphd: Hydroxychloroquine +/- Azithromycin in Mild-to-Moderate Covid-19 [Jul 23, 2020] Cavalcanti et al. @NEJM https://t.co/GUM6OwRG6…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @JFernandeznino: Otro artículo que no encuentra eficacia de la hidroxicloroquina
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @drmiguelmarcos: Otro estudio randomizado que NO muestra eficacia de la hidroxicloroquina (ni con azitromicina) en #COVID19 Probablement…
RT @PauloLotufo: Brasil chuta a cloroquina. Parabéns, aos meus seguidores @f_g_zampieri @leticiakawano pela publicação e pelo sigilo mantid…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @besteves: mais uma evidência de que a hidroxicloroquina não é eficaz em pacientes com quadros leves ou moderados de covid-19, combinada…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @GermHunterMD: Another RCT of HCQ in hospitalized patients with COVID19, this time limited to mild-to-moderate severity (<4 L of O2), an…
Saiu o Coalizão I - estudo brasileiro que testou HCQ com e sem AZT - Não funciona https://t.co/HR0Gx6S1dE
Enfiem na cabecinha de vocês: COVID ainda não tem tratamento eficaz! Infelizmente ! Vamos torcer para a vacina !
RT @Barbusceptique: HCQ, fin de partie numéro 36. https://t.co/2p9MDY7FGF
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @JFernandeznino: Otro artículo que no encuentra eficacia de la hidroxicloroquina
Já passou da hora de aposentar esse tipo de tratamento
RT @docramiro: Otro ensayo clínico que muestra -de nuevo- que no existe mejoría clínica en pacientes con COVID19 leve o moderado usando Hid…
Brazil producing science in the pandemic and publishing at NEJM
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @EMSwami: No benefit for HCQ w/ or w/o azithro in mild to moderate #COVID19 https://t.co/8sDSLiuPCG @FlaviaSepsis + colleagues Increase…
@DeplorableMrD Here is another study showing Hydroxy is not showing either safety or efficacy for C19 patients. From the New England Journal of Medicine. https://t.co/kFN95VziYL
RT @SaudenoBR: Que momento da ciência brasileira! No mesmo dia, um artigo na Science e um na New England Journal of Medicine liderados e de…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
Os fãs de Biroliro não levam isso em consideração. Se Biroliro disse, é verdade. Se Biroliro toma, eu tomo. Se Biroliro sai sem Máscara, eu saio. E assim por diante.... #ForaBolsonaro
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
"Among patients hospitalized with mild-to-moderate Covid-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care." https://t.co/c97gpKZsZL
Mais uma pá de cal na cloroquina, agora estudo feito no Brasil com 667 pacientes: "Entre os pacientes hospitalizados com Covid-19 leve a moderado, o uso de cloroquina, sozinho ou com azitromicina, não melhorou o estado clínico em 15 dias, em comparação com
@raoult_didier Ah ben tenez, vous êtes cité là... par contre la conclusion va pas vous plaire https://t.co/rYEgYzKt6T https://t.co/gkg6Eej0fO
https://t.co/8UAdWcCYmp Matéria pra até presidente ver. Quem sabe entenda a parte que diz que a hidroxicloroquina NÃO FUNCIONA! Marquem o presidente de vocês @jairbolsonaro !
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
RT @CMichaelGibson: Among patients hospitalized with mild-to-moderate #Covid19, the use of hydroxychloroquine, alone or with azithromycin,…
No benefit of HCQ + Azithromycin in Mild-to-Moderate Covid-19. You can’t say it hasn’t been well studied. Someone will probably say, *but* what about HCQ + Zinc. https://t.co/TPEuALWY7B
A Brazilian trial showed no benefit of #Hydroxychloroquine with or without #Azithromycin in Mild-to-Moderate #COVID19 -19 | @NEJM https://t.co/y6KlUmvqIP
@QuebrandoOTabu Link do artigo publicado https://t.co/z12d8eoo4O
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @pmarsupia: Nuevo ensayo clínico sobre medicamentos frente al Covid: 👉🏽 La hidroxicloroquina NO funciona sola. 👉🏽 La hidroxicloroquina…
RT @EMSwami: No benefit for HCQ w/ or w/o azithro in mild to moderate #COVID19 https://t.co/8sDSLiuPCG @FlaviaSepsis + colleagues Increase…
RT @PauloLotufo: Alô ! Imprensa brasileira. Médica de primeira linha e pesquisadora qualificada. Incrível, conheço vários dos autores, alg…
RT @GermHunterMD: Another RCT of HCQ in hospitalized patients with COVID19, this time limited to mild-to-moderate severity (<4 L of O2), an…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
Big, robust Brazilian hydroxychloroquine trial on mild COVID-19 patients - the group Bolsonaro likes it used on - finds the drug “did not improve clinical status at 15 days as compared with standard care.” https://t.co/o14U2VTGeR
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…